HTBA Acquires Specnova to Enhance Ingredient Delivery Technologies
Health Tech Bio Actives (HTBA), based in Barcelona, announced on October 6, 2026, its acquisition of Specnova, a US biotechnology company known for its functional ingredient delivery technologies. This move represents HTBA's first acquisition and signifies a strategic milestone for both companies. The financial specifics of the deal were not disclosed, but the companies plan to collaborate closely while maintaining their independent operations.
HTBA specializes in producing citrus flavonoids and active forms of vitamin B12, serving various sectors such as nutraceuticals, pharmaceuticals, food and beverages (F&B), and animal nutrition. Specnova, headquartered in Virginia, has developed several advanced ingredient delivery solutions, including its LipoVantage platform, which uses liposomes to promote active ingredient absorption, and NovaOSpheres technology, known for its controlled release capabilities using multi-layered beadlets.
The acquisition will provide HTBA with access to new opportunities in the US market, leveraging Specnova's expertise to enhance product formats and performance. In return, Specnova will benefit from HTBA's extensive global commercial network, facilitating market expansion beyond North America.
HTBA's CEO, Alexandre Valls-Coma, emphasized the strategic fit of Specnova's technologies, stating that they complement HTBA's existing offerings and will catalyze future developments. Specnova's founder and CEO, Sebastian Balcome, also highlighted the compatibility of both companies' missions, focusing on innovation and effective raw materials in the natural products industry.
Both leaders expressed a shared commitment to science and technology, ensuring continued focus on technology, clinical research, and customer service. The acquisition promises to expand the scope of offerings available to existing and new customers as the companies work together to enhance their portfolios in the food, beverages, and supplements sectors.
